Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.440
-1.490 (-50.85%)
At close: Jun 29, 2026, 4:00 PM EDT
1.400
-0.040 (-2.78%)
After-hours: Jun 29, 2026, 4:23 PM EDT

Bluejay Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1232850
Market Cap Growth
-45.18%-40.20%78.58%-80.30%-84.62%-
Enterprise Value
-2.27-3.43-1.38-0.34-1.9530.84
Last Close Price
1.442.6719.481952.0012156.8081920.00
PS Ratio
----30.80-
PB Ratio
0.730.270.470.520.662.45
P/TBV Ratio
0.230.200.160.460.661.07
EV/Sales Ratio
-----7.84-
EV/EBITDA Ratio
-0.510.200.040.22-
EV/EBIT Ratio
-0.490.190.030.21-
EV/FCF Ratio
-0.550.170.040.22-
Debt / Equity Ratio
-0.000.020.070.030
Net Debt / Equity Ratio
-0.86-0.84-0.71-0.64-0.83-0.93
Net Debt / EBITDA Ratio
0.530.740.590.201.076.18
Net Debt / FCF Ratio
0.560.810.500.211.084.34
Asset Turnover
-0000.010
Quick Ratio
2.614.615.311.256.1729.89
Current Ratio
2.814.886.051.827.1932.43
Return on Equity (ROE)
-135.94%-117.02%-178.98%-137.90%-58.25%-34.79%
Return on Assets (ROA)
-110.13%-100.94%-124.41%-112.14%-53.95%-28.67%
Return on Invested Capital (ROIC)
-402.02%-383.35%-389.39%-550.61%-570.13%-215.01%
Return on Capital Employed (ROCE)
-137.52%-117.38%-160.32%-137.68%-57.76%-32.22%
Buyback Yield / Dilution
-724.65%-879.42%-6590.70%-8.75%-136.60%-170.79%
Total Shareholder Return
-724.65%-879.42%-6590.70%-8.75%-136.60%-170.79%
SEC Filings: 10-K · 10-Q